Cubol, Emelda D.

HRN: 28-68-45  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/09/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/09/2026
03/15/2026
IV
600mg
Q8
Urosepsis And DM Foot Right
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary TractSkin & Soft Tissue    Compliance to guidelines: